In the context of COVID-19, there are also cases of newly diagnosed adrenal insufficiency (AI) confirmed by the adrenocorticotropic hormone (ACTH) stimulation test, and their incidence, depending on the study, reaches up to 64% [114,115,116]. The gene discussed is POMC; the disease is COVID-19.